Kumar, Manish (2023) Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics. [Preprint]
This is the latest version of this item.
Text
Precision Oncolog, Cancer Signaling & Targeted Therapy+).pdf - Updated Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) |
Abstract
Cancer is a fatal genetic disease with varying complexities, including immune evasion, treatment resistance and recurrence, and optimized treatment is needed for a proper cure. Molecular studies have revealed that tumors are extremely heterogeneous in nature, leading to the complexity of cancer development, which is ultimately linked to its genetic machinery. Importantly, patients with the same type of cancer respond differently to
available cancer treatments, indicating the need for patient-specific treatment options. Thus, in-depth genomic studies of patients’ tumors are needed to fully understand the determinants of cancer initiation and progression for effective targeted therapy. Precision oncology has evolved as a form of cancer therapy focused on genetic profiling of tumors to identify molecular alterations involved in cancer manifestation for tailored individualized treatment of the disease. There have been great developments in the formulation and production of anticancer agents in recent years, mainly owing to advances in molecular technologies enabling precise targeting of oncogenic pathways involved in disease progression. This article aims to briefly explain the foundations and frontiers of precision
oncology in the context of advancements in the tools and techniques associated with the process to assess its scope and importance in realizing the intended goals.
Export/Citation: | EndNote | BibTeX | Dublin Core | ASCII/Text Citation (Chicago) | HTML Citation | OpenURL |
Social Networking: |
Item Type: | Preprint | ||||||
---|---|---|---|---|---|---|---|
Creators: |
|
||||||
Additional Information: | Pictures and other related data have been taken from sources freely available for reuse or permission for the same can be obtained upon request. Pictures no. 1 and 2 have been added to the text with permission from Elsevier. (Order No. 5521991271884, dated 4th April 2023). 53 pages, 2 figures, and 1 table. | ||||||
Keywords: | Gene Mutation; Cancer Genomics; p53; K-Ras; C-Myc; Bcl-2, Cancer Stem Cells; Targeted Therapy; Immunotherapy, Precision Medicine | ||||||
Subjects: | Specific Sciences > Biology > Molecular Biology/Genetics Specific Sciences > Medicine > Health and Disease |
||||||
Depositing User: | Mr, Manish Kumar | ||||||
Date Deposited: | 15 Oct 2024 13:02 | ||||||
Last Modified: | 15 Oct 2024 13:02 | ||||||
Item ID: | 24068 | ||||||
Official URL: | https://www.scienceopen.com/hosted-document?doi=10... | ||||||
DOI or Unique Handle: | 10.14293/PR2199.000553.v3 | ||||||
Subjects: | Specific Sciences > Biology > Molecular Biology/Genetics Specific Sciences > Medicine > Health and Disease |
||||||
Date: | 21 December 2023 | ||||||
URI: | https://philsci-archive.pitt.edu/id/eprint/24068 |
Available Versions of this Item
- The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signaling Pathways is a Means to an End. (deposited 15 Feb 2024 02:11)
Monthly Views for the past 3 years
Monthly Downloads for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
View Item |